Correction: Evaluating the therapeutic efficacy of gastramide theranostics targeting cholecystokinin-2 receptors in a preclinical setting

RSC Advances 2026 Open access

Read full text
Authors: Marwa Nadia Rahimi, Jo‐Anne Pinson, J.P. Hilton-Proctor, Jessica Van Zuylekom, Benjamin J. Blyth, Peter D. Roselt, Mohammad B. Haskali
DOI: 10.1039/d6ra90008a
Cited by: 0

Abstract

Correction for ‘Evaluating the therapeutic efficacy of gastramide theranostics targeting cholecystokinin-2 receptors in a preclinical setting’ by Marwa N. Rahimi et al. , RSC Adv. , 2026, 16 , 2123–2132, https://doi.org/10.1039/D5RA08789A.

Fields of Study & Subjects

Radiopharmaceutical Chemistry and Applications Nanoplatforms for cancer theranostics Neuropeptides and Animal Physiology

Publication details

Journal / source
RSC Advances
Volume
16
Issue
10
Pages
8693–8694
Publication date
1 January 2026
Language
EN